Oversupply, Flexibility, Biomanufacturing and The Future of This Region’s Life Science Sector
What You’ll Learn:
- How will lower interest rates influence biotech funding, investment flows, and real estate capital allocation in 2025?
- With a record volume of new lab and GMP supply delivering this year, how can owners make their assets stand out in a crowded market?
- Is renewed activity in biotech IPOs and venture funding a sign of sustained momentum heading into 2026?
- How is Boston’s biotech ecosystem continuing to foster innovation, and what distinctive advantages will support its rebound?
- What impact have major development projects across Greater Boston had on advancing the region’s life sciences growth and competitiveness?
- As vacancy climbs above 30% in Greater Boston, is the balance of power shifting further toward tenants, and what will they expect from new space?
- How is technology driving the demand for flexible, adaptable labs and GMP facilities that can evolve with science?
- In what ways has tenant demand for modular layouts, spec suites, and shorter lease terms reshaped leasing dynamics in 2025?
- Why is biomanufacturing becoming a stabilizing force for the market, and how are GMP facilities attracting both tenants and investors?
